- Home
- PRGS vs ENOV Comparison
PRGS vs ENOV Comparison
Compare PRGS & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGS
- ENOV
- Stock Information
- Founded
- PRGS 1981
- ENOV 1995
- Country
- PRGS United States
- ENOV United States
- Employees
- PRGS N/A
- ENOV N/A
- Industry
- PRGS Computer Software: Prepackaged Software
- ENOV Fluid Controls
- Sector
- PRGS Technology
- ENOV Industrials
- Exchange
- PRGS Nasdaq
- ENOV Nasdaq
- Market Cap
- PRGS 2.4B
- ENOV 2.1B
- IPO Year
- PRGS 1991
- ENOV 2008
- Fundamental
- Price
- PRGS $62.32
- ENOV $30.11
- Analyst Decision
- PRGS Buy
- ENOV Strong Buy
- Analyst Count
- PRGS 7
- ENOV 5
- Target Price
- PRGS $73.71
- ENOV $58.00
- AVG Volume (30 Days)
- PRGS 388.4K
- ENOV 1.3M
- Earning Date
- PRGS 06-30-2025
- ENOV 08-06-2025
- Dividend Yield
- PRGS 0.28%
- ENOV N/A
- EPS Growth
- PRGS N/A
- ENOV N/A
- EPS
- PRGS 1.27
- ENOV N/A
- Revenue
- PRGS $806,739,000.00
- ENOV $2,150,191,000.00
- Revenue This Year
- PRGS $30.62
- ENOV $8.23
- Revenue Next Year
- PRGS $2.43
- ENOV $6.18
- P/E Ratio
- PRGS $49.37
- ENOV N/A
- Revenue Growth
- PRGS 12.85
- ENOV 18.32
- 52 Week Low
- PRGS $48.00
- ENOV $29.13
- 52 Week High
- PRGS $70.56
- ENOV $49.83
- Technical
- Relative Strength Index (RSI)
- PRGS 55.88
- ENOV 38.02
- Support Level
- PRGS $62.38
- ENOV $31.48
- Resistance Level
- PRGS $64.11
- ENOV $32.61
- Average True Range (ATR)
- PRGS 0.97
- ENOV 1.11
- MACD
- PRGS -0.15
- ENOV -0.11
- Stochastic Oscillator
- PRGS 58.40
- ENOV 20.12
About PRGS Progress Software Corporation (DE)
Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.